PubRank

Joan Seoane

Author PubWeight™ 41.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Smad transcription factors. Genes Dev 2005 13.43
2 Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235. Cancer Res 2008 3.70
3 TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 2010 3.69
4 TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009 3.38
5 High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 2007 3.27
6 A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci U S A 2006 2.60
7 USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med 2012 1.93
8 Circulating tumour cells and cell-free DNA as tools for managing breast cancer. Nat Rev Clin Oncol 2013 1.33
9 TGF-beta signalling-related markers in cancer patients with bone metastasis. Biomarkers 2008 1.09
10 Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer. Invest New Drugs 2014 1.04
11 Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta. J Biol Chem 2004 0.99
12 Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation. Cancer Discov 2013 0.91
13 Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis. Exp Cell Res 2009 0.90
14 New approach to cancer therapy based on a molecularly defined cancer classification. CA Cancer J Clin 2013 0.82
15 TGFbeta and cancer initiating cells. Cell Cycle 2009 0.79
16 Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1. Oncotarget 2014 0.76
17 Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells. J Med Chem 2012 0.76
18 Circulating tumour cells in early breast cancer. Lancet Oncol 2012 0.75
19 Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer 2017 0.75